| Literature DB >> 17986127 |
Takashi Fujishita1, Mika Kishida, Hirofumi Taki, Chie Shinoda, Koutarou Miyabayashi, Masayo Fujishita, Muneharu Maruyama, Yutaka Mizushima, Masashi Kobayashi.
Abstract
We present a case of thymic carcinoid, in which primary and metastatic lesions of lymph nodes and bones could be detected by [(18)F]fluoro-2-deoxy-D-glucose (FDG)-PET, but not by (123)I-meta-iodobenzylguanidine ((123)I-MIBG) SPECT, or by (99m)Tc-methylene diphosphonate ((99m)Tc-MDP) bone scintigraphy. FDG-PET may be a useful tool for managing thymic carcinoids in patients with negative results on (123)I-MIBG SPECT or (99m)Tc-MDP imaging.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17986127 DOI： 10.1111/j.1440-1843.2007.01161.x
Source DB: PubMed Journal: Respirology ISSN： 1323-7799 Impact factor: 6.424